GlassScriptPhysician profile
Holly E Noonan
NPI 1356393516
$2,567.72
in general payments reported to CMS, 2019-2025
25 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $197 · 2021: $423 · 2022: $588 · 2023: $583 · 2024: $284 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $747.25 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $361.51 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $325.80 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $264.97 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $133.58 | 2019-2022 | |
| Astellas Pharma US INC | $112.81 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $99.18 | 2022 | |
| Hologic Sales and Service, LLC | $68.38 | 2019-2025 | Fluent Fluid Management System, Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $62.98 | 2020-2022 | |
| Millicent US INC | $51.65 | 2025 | Femlyv |
| Amgen INC. | $43.18 | 2019-2020 | |
| Evofem Biosciences, INC. | $39.16 | 2020-2022 | |
| Allergan, INC. | $33.61 | 2019-2020 | |
| Shield Therapeutics INC | $32.46 | 2024-2025 | |
| Agile Therapeutics, INC. | $30.83 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $24.27 | 2019-2020 | |
| Organon LLC | $19.74 | 2024 | |
| Sage Therapeutics, LLC | $17.04 | 2025 | Zurzuvae |
| Scynexis, INC. | $16.44 | 2022 | |
| Smith+Nephew, INC. | $16.26 | 2025 | Pico |
| Pfizer INC. | $15.74 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.63 | 2019 | |
| Duchesnay USA Incorporated | $12.66 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.99 | 2019 | |
| Ethicon US, LLC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Noonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.